Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves' disease: a systematic scoping review.

Published in: Journal of endocrinological investigation (2022)

Long-term ATD treatment for more than 60 months is safe and effective, has the highest remission rate and cures most patients with GD; hence, it should be considered as the most appropriate duration for ATD therapy in these patients.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
emergency department
stem cells
prognostic factors
peritoneal dialysis
rheumatoid arthritis
systemic lupus erythematosus
combination therapy
patient reported outcomes